The Latest Cardiac and Vascular News
CINCINNATI, Oct. 20, 2020 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”), a clinical-stage biopharmaceutical company developing medications targeting cardiovascular disease, announced today that they have dosed the first subject in the brigHTN study. The brigHTN study is a Phase 2 clinical trial evaluating the blood pressure lowering effects of CIN-107, […]
MIAMI, Oct. 20, 2020 (GLOBE NEWSWIRE) — Organicell Regenerative Medicine, Inc. (OTCBB: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced that it has recently entered into an agreement with Regenerative Care Network (“RCN”). Organicell and RCN plan to collaborate on clinical research projects investigating use […]
Real-world findings helped in decision making to remove drug’s prior authorization EAGAN, Minn., Oct. 20, 2020 /PRNewswire/ — Sacubitril-valsartan (Entresto®) has been proven to decrease hospitalization and reduce death due to heart failure with reduced ejection fraction (HFrEF) also known as systolic heart failure. 1 According to a recent study by Prime Therapeutics LLC […]
NEW YORK, Oct. 20, 2020 (GLOBE NEWSWIRE) — via NewMediaWire ‒ Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, today announced the appointment of Stuart Bernstein as Vice President of Marketing. In this role, Bernstein will be responsible for Brain Scientific’s overall marketing strategy and efforts to strengthen the company’s market […]
Bringing together science, technology, and comprehensive solutions to redefine what’s possible in healthcare ST. PAUL‚ Minn. & OAKLAND, Calif.–(BUSINESS WIRE)–As the world of healthcare and its dependence on auscultation continues to evolve, digital technology is being introduced to meet the advancing demands of the industry. To meet these changing needs, 3M™ […]
OPTIMIZE Pivotal Study 1 Year Outcomes Announced at TCT Connect NEW PROVIDENCE, N.J.–(BUSINESS WIRE)–The Svelte® Drug-Eluting Stent (DES) achieved 1.5% clinically-driven Target Lesion Revascularization (TLR) at 1 year, the lowest ever reported in an Investigational Device Exemption (IDE) clinical study. Primary and secondary endpoint outcomes of the OPTIMIZE IDE study, designed […]
Uses Cash to Pay Down Debt PLANO, Texas, Oct. 19, 2020 (GLOBE NEWSWIRE) — Integer Holdings Corporation (“Integer”) (NYSE: ITGR), a leading medical device outsource manufacturer, received approximately $28 million following the Federal Court of Appeals for the Federal Circuit affirming, in all respects, the ruling in Integer’s favor granted […]
October 19, 2020 Philips delivers Q3 sales of EUR 5.0 billion, with 10% comparable sales growth; income from continuing operations increases to EUR 341 million, Adjusted EBITA margin improves 300 basis points to 15.4%, and operating cash flow increases to EUR 770 million Philips provides new financial targets for the […]
ANN ARBOR, Mich., Oct. 19, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR), today announced it will report third quarter 2020 financial results after the close of the U.S. financial markets on Monday, November 2, 2020. Following the release, company management will host a webcast and conference call at 4:30 p.m. […]
IRVINE, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced positive results of the first 230 patients enrolled in its FLASH study. Interim […]
